Background: Herein we describe a small-diameter vascular graft constructed from rolled human amniotic membrane (hAM), with in vitro evaluation and subsequent in vivo assessment of its mechanical and initial biologic viability in the early postimplantation period. This approach for graft construction allows customization of graft dimensions, with wideranging potential clinical applicability as a nonautologous, allogeneic, cell-free graft material. Methods: Acellular hAMs were rolled into layered conduits (3.2-mm diameter) that were bound with fibrin and lyophilized. Constructs were seeded with human smooth muscle cells and cultured under controlled arterial hemodynamic conditions in vitro. Additionally, the acellular hAM conduits were surgically implanted as arterial interposition grafts into the carotid arteries of immunocompetent rabbits. Results: On in vitro analysis, smooth muscle cells were shown to adhere to, proliferate within, and remodel the scaffold during a 4-week culture period. At the end of the culture period, there was histologic and biomechanical evidence of graft wall layer coalescence. In vivo analysis demonstrated graft patency after 4 weeks (n [ 3), with no hyperacute rejection or thrombotic occlusion. Explants displayed histologic evidence of active cellular remodeling, with endogenous cell repopulation of the graft wall concurrent with degradation of initial graft material. Cells were shown to align circumferentially to resemble a vascular medial layer. Conclusions: The vascular grafts were shown to provide a supportive scaffold allowing cellular infiltration and remodeling by host cell populations in vivo. By use of this approach, "off-the-shelf" vascular grafts can be created with specified diameters and wall thicknesses to satisfy specific anatomic requirements in diverse populations of patients. (J Vasc Surg 2017;65:839-48.) 
Atherosclerotic cardiovascular disease remains the leading cause of mortality worldwide, with arterial bypass grafting representing an important therapeutic intervention. 1 Whereas autologous arteries have the highest success rates as bypass grafts, inessential and nondiseased arteries are in short supply, such that the need for enduring vascular replacements remains an urgent clinical priority. 2, 3 Tissue engineering by self-assembly represents a strategy for vascular graft assembly that uses autologously derived cells to secrete extracellular matrix (ECM) sheets that can subsequently be rolled into vascular constructs. 4 Motivated by the clinical successes of this approach in nonurgent procedures, herein we investigate a similar yet expeditious approach to develop a rolled vascular graft that could be available on an emergent basis for allogeneic use. 5 Similar to the pioneering tissue engineering by selfassembly cell-sheet technology described by L'Heureux et al, thin ECM sheets of human amniotic membrane (hAM) can be rolled around a supportive mandrel into multilayered wall conduits. 4, 6 Owing to its perinatal origin, the human amnion does not elicit an adverse immune response even in its native, cellular form, making it an ideal matrix for regenerative therapies. [7] [8] [9] The hAM has the additional advantage of abundant availability and has been clinically used in other applications with success for more than a century. [10] [11] [12] [13] Whereas a cell-mediated fusion of the layers has proved successful in preliminary studies, this study investigated the use of freeze-drying in conjunction with a fibrin sealant to bind adjacent layers.
Without the need for prepopulation with autologous cells, the conduits would be readily available, easily transportable, and storable for extended times.
With a rolling approach, vascular graft dimensions can be prepared to custom specification. An acellular graft should be able to withstand surgical implantation, be tolerated by the host, and support host cell remodeling of the scaffold into vascular tissue. As such, our research question was threefold: (1) Can a vascular graft derived from decellularized human amnion mechanically endure initial surgical implantation into arterial systemic circulation? (2) Will such a vascular graft survive into the early postoperative period without eliciting hyperacute rejection or thrombosis? and (3) Will such a vascular construct demonstrate histologic evidence of early cellular remodeling reminiscent of native vascular architecture?
METHODS

Experimental design
The hAMs were decellularized and rolled into tubular conduits for in vitro and in vivo investigation. For preliminary study of early graft remodeling in vitro, grafts were seeded with human smooth muscle cells and cultured for 28 days to assess the influence of pulsatile fluid forces on cell-mediated changes to scaffold biochemical and biomechanical composition. For the in vivo study, the hAM grafts were implanted in rabbit carotid arteries for a 4-week period to assess initial host tolerance of the graft as well as early cellular remodeling. Study design and methods conform to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23). This study was performed after approval was obtained from the University of Florida's Animal Care Services and Institutional Animal Care and Use Committee (#VA89, VA #0028).
Graft preparation
The hAMs were separated from the chorion by blunt dissection and decellularized as previously described using sodium dodecyl sulfate and DNAse I. 14, 15 The hAM ECM was cut into 60 Â 60-mm sheets, rehydrated with 50 mg/mL fibrinogen, and rolled around 3.2-mm outer diameter tubing. The resultant six-layered hAM scaffolds were then treated with thrombin to catalyze the formation of fibrin and freeze-dried. Samples were then washed in successive phosphate-buffered saline rinses (5, 15, and 40 minutes; 1 hour; and 6 hours) before a final freeze-drying step. Samples were rehydrated with sterile phosphate-buffered saline 30 minutes before implantation.
In vitro studies
Cell expansion and culture. Primary human smooth muscle cells were explanted from umbilical arteries and cultured at subconfluent densities as previously described. 14 On the basis of previous work that optimized cell seeding density (unpublished), the abluminal surface of the graft was seeded at a density of 600 cells/mm 2 . 14 Dynamic culture was performed in custom bioreactors connected within a dual-circuit perfusion system. Two peristaltic pumps were used to independently control the luminal and abluminal flow circuits. Luminal flow rate and pressure were ramped during the first 10 days to reach a final maximum pressure of 120 mm Hg and pulse rate of 1 Hz; the abluminal flow was maintained at 5 mL/min throughout the duration of the 4-week culture period.
Biochemical and histologic analysis. Samples were digested using 125 mg/mL papain (Spectrum, Gardena, Calif) for 24 hours at 60 C. Smooth muscle cell proliferation was assessed, by quantification of total construct DNA, using the Quant-iT PicoGreen DNA assay (Invitrogen, Eugene, Ore). Glycosaminoglycan (GAG) content was assayed using dimethylmethylene blue (Sigma-Aldrich, St. Louis Mo). [15] [16] [17] Acellular scaffolds were imaged under scanning electron microscopy as previously reported. 14 Samples were embedded in Neg-50 media, frozen, sectioned, and stained with hematoxylin and eosin using standard protocols.
Biomechanical analysis. Tensile properties were assessed using an Instron (Norwood, Mass) uniaxial testing rig (model 5542 with version 2.14 software) as previously reported.
14 Burst pressure was determined using a modified syringe pump to increase luminal pressure within the 6-cm-long scaffolds until failure. The distal end of each construct was sealed with a pressure transducer immediately downstream of the scaffold to determine the ultimate pressure at failure. Each test was digitally recorded to measure vessel distention at a given pressure using ImageJ software (National Institutes of Health, Bethesda, Md).
In vivo studies
Graft implantation. Acellular grafts were prepared from human amnion as described before to match the inner diameter and wall thickness of New Zealand white rabbit carotid arteries (approximately 3.2 mm and 300 mm, respectively). Scaffolds were implanted in the common carotid arteries of male New Zealand white rabbits using an anastomotic cuff technique as previously described, with polyethylene cuffs (3.0-3.5 kg; n ¼ 3). 18 The 4-week length of implantation was selected following preliminary evaluation of the extent of graft remodeling after 1 week of implantation (n ¼ 1).
All operations lasted approximately 15 minutes on average, used aseptic technique, and were performed under an operating microscope. Before graft implantation, 1000 units of heparin was administered intravenously. Anesthesia was initiated by 30.0 mg/kg intramuscular ketamine hydrochloride and maintained by inhaled isoflurane (2.5%-3.0%) through endotracheal intubation. Perfusion through the carotid arteries was recorded using an ultrasonic transducer (model T106, probe 2SB; Transonic Systems Inc, Ithaca, NY). Neurologic assessment of each rabbit appraised potential cerebrovascular compromise. No postsurgical medical therapy was necessary.
Histologic analysis. Explanted tissue was fixed in 10% formalin, paraffin embedded, and sectioned. Samples were stained with Masson trichrome using standard histologic techniques. Midgraft sections were used to evaluate the thickness of the wall. Wall thickness was measured using ImageJ software.
Statistical analysis
All data are presented as mean values 6 standard deviation from at least three independent experiments (n ¼ 3) for biochemical assays and at least five independent experiments (n ¼ 5) for biomechanical tests. Statistical analysis was performed using a Student t-test with significant differences corresponding to a P < .05 (confidence level $95%).
RESULTS
Fig 1,
A shows the change in gross appearance between a single dry ECM sheet and laminated sheets of increasing thicknesses. Initial durability testing verified that acellular grafts withstood 24 hours of 1 Hz pulsatile perfusion culture at approximately 80 to 120 mm Hg without delamination and had burst pressures of 1430 6 250 mm Hg. Cross-sectional views of the rolled scaffolds under scanning electron microscopy display the smooth surface of the amniotic basement membrane that forms the abluminal surface of the tubular scaffold (Fig 1, B) . Association of adjacent layers that form the six-layered wall can be observed at a higher magnification (Fig 1, Bi) . As an example of variation in rolled geometry, scaffolds with internal diameters of 3. In vitro studies: Cell repopulation and early graft remodeling. The schematic diagram of the dual-perfusion circuit is shown in Fig 2, B. A downstream pressure regulator was used to maintain a maximum luminal pressure of 120 mm Hg from day 10, as shown in Fig 2, C. On initial rehydration, the translucent acellular tubular scaffolds collapse (Fig 3, A) ; however, after 4 weeks of dynamic culture, the construct is visibly opaque and able to maintain a tubular conformation without additional mechanical support (Fig 3, B) . A histologic assessment of the acellular scaffold (Fig 3, C) and the dynamically stimulated construct (Fig 3, D) shows that the initially laminated wall coalesced after 28 days in perfusion culture. Cell densities and GAG content each displayed statistically significant increases between days 14 and 28. Cell density increased sevenfold from 13.7 to 97 million cells per gram of the cultured construct, and GAG content increased from 5.4 to 37.6 mg/g of wet tissue in the final 2 weeks of culture (Fig 3, E and F, respectively) .
Remodeling of the constructs' laminated walls during the 4-week perfusion culture period resulted in changes in the representative load-extension profile compared with acellular grafts (Fig 4, A) . Constructs displayed increased modulus values (stiffer) with a single fracture point when tensioned to failure after 4 weeks of perfusion culture. Fig 4, B is a schematic of a stress-strain curve to demonstrate the regions of the curve from which the mechanical properties were derived. After 28 days of perfusion culture, constructs maintained the initial scaffold's tensile properties with trends toward a decreasing physiologic modulus (from 120 6 54.6 kPa to 60 6 26.0 kPa; Fig 4, C) and an increasing Young's modulus (from 694 6 227 kPa to 1290 6 593 kPa ; Fig 4, D) . No significant changes were noted in the scaffold's ultimate tensile strength from 854 6 272 kPa as an acellular scaffold to 878 6 447 kPa by the conclusion of the study at 28 days (Fig 4, E) .
In vivo studies: Ultrasound and histomorphic evaluation. Acellular human-derived grafts were interposed into the carotid arteries of four New Zealand white rabbits. 18 Grafts were described by the surgeons to have acceptable handling properties. Complete reperfusion was visualized grossly and confirmed by ultrasound (Fig 5, A  and C) . No erratic behavior was observed in the neurologic assessments, and there was no statistically significant change in animal weight. No acute rejection occurred, and no thrombotic response was detected by ultrasound. At day 28 explantation, one graft exhibited nonoccluding thrombus formation at the distal anastomosis; the other two appeared grossly patent.
Gross appearance of the graft in the longitudinal view is also shown immediately before explantation (Fig 5, B) . At explantation, grafts were enveloped by a thin, highly vascularized tissue and displayed pulsation patterns synchronous with the adjacent native carotid artery. Doppler ultrasound at explantation showed graft patency at 4 weeks (Fig 5, D) . No statistically significant changes were noted in average local blood flow rate through the graft during the course of the implantation (28 6 21 mL/min at implantation and 23 6 19 mL/min at 4 weeks; Fig 5, E) . The mean internal luminal diameter decreased, without statistical significance, from 3.2 to 2.5 mm, and the wall thickness of the graft at the midpoint increased significantly from approximately 300 to 500 mm (Fig 5, F and G, respectively) .
Significant graft remodeling was noted on histologic examination between 1 week and 4 weeks after implantation (Fig 6, A and B, respectively) . This was evidenced by changes in observable mural cell density, connective tissue deposition, and overall increased consolidation of graft layers over time. The external (adventitial) layers of the construct were histologically notable for a homogeneous Graft preparation and in vitro conditioning. Decellularized amniotic membranes (A, i) were freeze-dried, followed by rehydration with fibrinogen (A, ii). Scaffolds were then rolled, and thrombin was applied to catalyze the cross-linking. Last, the scaffolds were freeze-dried (A, iii). Scaffolds were mounted in bioreactors (A, iv) before seeding. Constructs mounted in bioreactors were connected in the dual-perfusion circuit as shown schematically (B). An incremental luminal flow regimen was applied to allow time for initial cellular adhesion to the scaffold surface. As the flow rate was increased, the check valve was used to regulate the pressure of the flow circuit such that a maximum luminal pressure of 120 mm Hg was obtained 10 days after cell seeding. The abluminal flow was held constant at 5 mL/min throughout the study (C).
pattern of organized connective tissue deposition, associated with an interspersed, uniform-appearing population of cells with mild to moderate density throughout the stroma. These cells and connective tissue pattern corresponded to construct layers demonstrating consolidation and coalescence. In contrast, the internal (luminal) layers of the construct demonstrated a pattern of loose, disorganized connective tissue deposition associated with a highdensity cell population. Cell distribution within the wall of the explant is easily visualized in the Supplementary Fig, A (online only). Circumferentially aligned cellular populations (elongated in the direction of the dotted line in Fig 6, Bi) appeared to morphologically approximate a vascular medial layer and displayed strong positive reactivity for a-actin ( Supplementary Fig, B , online only). Fig 6, C highlights the apparent remnants of the original six-layered hAM graft, reduced to only two discrete collagen-dense layers. Small capillaries were seen forming in the periphery of the vascular wall, as noted grossly in situ at the time of explantation and on subsequent histologic analysis (Fig 6, Ci, arrows) . Immunohistochemical study with CD31 demonstrated equivocal reactivity for endothelial elements along the construct lumen but verified the establishment of peripheral microvasculature ( Supplementary Fig, B, online only) .
Inflammatory cell infiltrate was histologically identified. A patchy distribution of predominantly mononuclear and plasmacytoid inflammatory cells was identified within the wall of the construct. Rather than a transmural distribution, the inflammatory cells were seen to preferentially infiltrate along the identifiable ECM layers near the lumen as well as radially along the external adventitia-like zone. Isolated neutrophils and eosinophils were focal and rare.
DISCUSSION
The goal of these investigations was to conduct a preliminary feasibility assessment of using a cell-less, human-derived scaffold in service of small-diameter vascular regeneration. This pilot study assessed, on both an in vitro and in vivo basis, three essential scaffold requirements for guided tissue regeneration: (1) maintenance of structural integrity, (2) lack of thrombosis or hyperacute rejection, and (3) promotion of cellular remodeling to suggest an attempt to approximate arterial vasculature. The in vitro analyses focused primarily on the feasibility of cellular repopulation in a layered construct and the consequences of the repopulation on the grafts' mechanical stability and biochemical changes under controlled conditions. Unlike the acellular scaffold that collapses after rehydration without external physical support, cultured constructs displayed a qualitatively robust tubular conformation, with layers coalescing into a homogeneous wall on gross and histologic inspection. Statistically significant increases in GAG concentration and cell density suggest that the scaffold provides a hospitable environment for cellular integration and proliferation, potentially facilitating extensive ECM remodeling.
The coalescence of graft layers after 4 weeks in biomimetic culture correlated with increasing material stiffness and ultimate tensile strength. Biomechanical parameters were on the same order of magnitude as those described of healthy human coronary arteries, which served as the target vessel for graft replacement during in vitro investigation. Karimi et al found that healthy human coronary arteries have elastic moduli of 1.55 6 0.26 MPa and ultimate tensile strengths of 1.44 6 0.87 MPa (compared with the 1.29 6 0.59 MPa and 0.88 6 0.45 MPa, respectively, found in this study). 19 Physiologic modulus of the cultured constructs, 0.06 6 0.03 MPa, was lower than that of published data for native human vessels, 1.48 6 0.24 MPa, and the acellular scaffolds, 0.120 6 0.0546 MPa, suggesting that the construct is more compliant during early stages of remodeling compared with the native vessel. This is consistent with increasing GAG concentration within the Biomechanical properties of in vitro constructs. Representative failure profile of graft ringlets tensioned until failure shows that typical failure profiles of acellular grafts displayed a lower failure point than constructs cultured for 4 weeks in pulsatile perfusion bioreactors. Constructs cultured for 28 days displayed a distinct failure point (A). Biomechanical parameters were calculated from the regions highlighted in a stress-strain curve schematic (B). Biomechanical analysis of grafts in vitro showing the physiologic modulus (C), Young's modulus (D), and ultimate tensile strength (E) of the acellular scaffolds (before culture) and after 28 days of biomimetic culture with smooth muscle cells. collagenous construct. However, vascular compliance is dynamic and known to be adaptive to the hemodynamic environment. 20, 21 The in vivo investigations served as a pilot proof of principle for targeting specific anatomic locations, evaluating early scaffold remodeling, and testing dynamic fatigue. 22 The acellular grafts endured the mechanical forces associated with surgical implantation and with the immediate exposure to the hemodynamic stress of systemic circulation. In this study, rabbits were immunocompetent, and no postsurgical pharmacologic treatment was administered. No hyperacute rejection of the biomaterial was noted clinically (as confirmed by the lack of vascular compromise on Doppler ultrasound after implantation), and all grafts remained patent during 28 days. No cerebrovascular compromise was noted. The histologic paucity of neutrophils and eosinophils suggests the absence of a nonspecific acute inflammatory response and allergic reaction, respectively. The absence of multinucleated foreign body giant cell formation was noted, suggesting the lack of a classic foreign body response to the graft.
Histologic analysis showed organized remodeling of the hAM layers, with complete cellular integration of circumferentially aligned, elongated, a-actin-positive population of cells, interspersed amid newly formed collagen. The pattern of connective tissue deposition from ablumen to lumen appears consistent with organized and still-active stromal remodeling, with appreciable capillary network In vivo pilot study. Human amnion-derived grafts were interposed in rabbit carotid arteries. A and B, Gross morphology. The blue tubing in A represents a 12.6-mm length. Longitudinal view of a representative graft at implantation (A) and at harvest 28 days later (B). At explantation, grafts were surrounded by a loose, thin cover of highly vascularized tissue. C and D, Analysis by Doppler ultrasound. Representative longitudinal views of grafts at implantation and harvest (C and D, respectively) reveal the patency of the graft after 4 weeks. The arrowheads indicate the location of the polyethylene cuffs. Mean flow rate at implantation (Implant) and after 28 days (Harvest) does not change significantly (E). The internal diameter (ID) of the lumen did not significantly decrease (F), but the mean wall thickness was significantly increased as indicated by the asterisk (P < .05; G).
formation in the graft periphery. It is interesting to note that the pattern of "early" connective tissue deposition near the lumen is associated with yet-discrete construct layers, suggesting a temporal heterogeneity to mural remodeling, with luminal consolidation occurring as a late-stage event.
The described rolling methodology allows a significant degree of patient-centered graft customization, effectively expanding the clinical applicability of this amnion-derived biomaterial. Fibrin adhesives can also be manufactured from a human origin, improving the feasibility of clinical translation. 23, 24 Diameter, length, wall thickness, and shape can be easily adjusted to generate custom vascular grafts for routine or complex vascular reconstruction in a variety of anatomic sites and populations of patients. This could include arteriovenous grafts to allow hemodialysis access for patients suffering from end-stage renal disease, coronary artery bypass grafts to prevent or to palliate ischemic heart disease, and personalized grafts for modified Fontan procedures to treat complex congenital heart disease in pediatric populations. Important areas for future work include detailed evaluation of graft functional remodeling capacity (eg, through phenotypic assessment of both stromal and inflammatory cellular elements) and study of graft longevity in vivo. These preliminary investigations focused on early remodeling to characterize the initial thrombogenicity and cellular integration, whereas longer in vivo analysis would be necessary to determine the resolution of these early remodeling events. Longer implantation times would additionally help to elucidate the biologic significance of the trending increase in wall thickness, potentially differentiating between progressive graft stenosis and transient phenomena of early remodeling.
CONCLUSIONS
This approach has multiple advantages: the material is derived from abundantly available human ECM, and it can be readily prepared into an acellular graft of a wide range of geometries. With endogenous biologic components, the ECM is readily degradable and, in theory, should allow in situ growth. This growth potential makes the scaffold particularly appealing for use in various applications, from treatment of adult coronary artery disease to vascular reconstruction of complex congenital heart disease in pediatric patients. As a preliminary investigation, these works have demonstrated that grafts possess adequate mechanical integrity, postoperative immunologic tolerance lasting at least 4 weeks, and evidence of cellular remodeling approximating the native vascular architecture. Further investigation that details cellular behavior, inflammatory infiltration, and graft longevity will aid in our understanding of in situ graft remodeling. As human tissue in a rabbit model, the human amnion-derived ECM scaffold showed signs of constructive remodeling and, with further investigation, holds promise as a platform for allogeneic vascular tissue reconstruction.
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